Monashee Investment Management LLC
13F Reported Value
ⓘ$183.8M
Holdings
45
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Monashee Investment Management LLC disclosed 45 positions worth $183.8M in its Form 13F-HR for Q1 2026, led by $TERN (Terns Pharmaceuticals, Inc.) at 8.6% of the equity portfolio. During the quarter the fund opened 30 new positions and exited 24 and a full exit from $SOFI. The portfolio is most concentrated in Healthcare (49.1% of disclosed assets). All figures are sourced directly from Monashee Investment Management LLC’s Form 13F-HR filing with the SEC under CIK 1627608.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- —
Quality
$15.8M300,000 sh NEXTERA ENERGY INC
—Quality
$15.2M299,970 sh- —
Quality
$13.3M300,000 sh - 59.5
Quality
$12.4M85,000 sh - —
Quality
$10.2M350,000 sh - —
Quality
$10.2M1,420,295 sh - 10.2
Quality
$7.2M100,000 sh - 28.0
Quality
$6.6M100,000 sh JOBY AVIATION INC
—Quality
$5.9M7,000,000 shPPL CORP
—Quality
$5.2M101,300 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| — | $15.8M | 300,000 | |
| NEXTERA ENERGY INC | — | $15.2M | 299,970 |
| — | $13.3M | 300,000 | |
| 59.5 | $12.4M | 85,000 | |
| — | $10.2M | 350,000 | |
| — | $10.2M | 1,420,295 | |
| 10.2 | $7.2M | 100,000 | |
| 28.0 | $6.6M | 100,000 | |
| JOBY AVIATION INC | — | $5.9M | 7,000,000 |
| PPL CORP | — | $5.2M | 101,300 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Monashee Investment Management LLC's 45 positions.
Showing top 10 of 45 holdings.
Sector Allocation
Healthcare
$90.3M
Other
$35.4M
Technology
$22.4M
Utilities
$13.9M
Financials
$8.8M
Industrials
$6.0M
Communication Services
$3.7M
Energy
$2.1M
Full Holdings — Monashee Investment Management LLC (Q1 2026)
All 45 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | Terns Pharmaceuticals, Inc. | $15.8M | 8.6% | +52% | — | |
| 2 | — | NEXTERA ENERGY INC | $15.2M | 8.3% | NEW | — |
| 3 | Medline Inc. | $13.3M | 7.3% | +0% | — | |
| 4 | NRG ENERGY, INC. | $12.4M | 6.8% | NEW | 59.5 | |
| 5 | Forgent Power Solutions, Inc. | $10.2M | 5.6% | NEW | — | |
| 6 | Solid Biosciences Inc. | $10.2M | 5.6% | +5% | — | |
| 7 | NEKTAR THERAPEUTICS | $7.2M | 3.9% | +6% | 10.2 | |
| 8 | CYTOKINETICS INC | $6.6M | 3.6% | +33% | 28 | |
| 9 | — | JOBY AVIATION INC | $5.9M | 3.2% | NEW | — |
| 10 | — | PPL CORP | $5.2M | 2.9% | NEW | — |
| 11 | BridgeBio Pharma, Inc. | $5.0M | 2.7% | -33% | 31.7 | |
| 12 | ADT Inc. | $4.6M | 2.5% | +75% | 66.2 | |
| 13 | — | ORACLE CORP | $4.5M | 2.5% | NEW | — |
| 14 | Evommune, Inc. | $4.1M | 2.2% | -2% | — | |
| 15 | KKR & Co. Inc. | $4.0M | 2.2% | NEW | 49.8 | |
| 16 | AST SpaceMobile, Inc. | $3.7M | 2.0% | NEW | 29.6 | |
| 17 | — | ZENAS BIOPHARMA INC | $3.2M | 1.8% | NEW | — |
| 18 | Sandisk Corp | $3.2M | 1.7% | NEW | 88.8 | |
| 19 | Veradermics, Inc | $3.2M | 1.7% | NEW | — | |
| 20 | Zenas BioPharma, Inc. | $2.9M | 1.6% | NEW | 14.4 | |
| 21 | Kymera Therapeutics, Inc. | $2.9M | 1.6% | -65% | 29.2 | |
| 22 | Ambiq Micro, Inc. | $2.6M | 1.4% | +22% | 46.3 | |
| 23 | MiniMed Group, Inc. | $2.6M | 1.4% | NEW | — | |
| 24 | Figure Technology Solutions, Inc. | $2.6M | 1.4% | NEW | — | |
| 25 | SpyGlass Pharma, Inc. | $2.5M | 1.3% | NEW | — | |
| 26 | Structure Therapeutics Inc. | $2.4M | 1.3% | -78% | — | |
| 27 | CRISPR Therapeutics AG | $2.4M | 1.3% | NEW | 4.5 | |
| 28 | Ingram Micro Holding Corp | $2.3M | 1.3% | NEW | 60.3 | |
| 29 | GLOBALFOUNDRIES Inc. | $2.2M | 1.2% | NEW | — | |
| 30 | enGene Therapeutics Inc. | $2.2M | 1.2% | +8% | — | |
| 31 | Flowco Holdings Inc. | $2.1M | 1.1% | NEW | 66.3 | |
| 32 | SAB Biotherapeutics, Inc. | $1.9M | 1.0% | NEW | — | |
| 33 | Aclaris Therapeutics, Inc. | $1.9M | 1.0% | NEW | 9.2 | |
| 34 | HALLADOR ENERGY CO | $1.5M | 0.8% | NEW | 50.4 | |
| 35 | Navigator Holdings Ltd. | $1.4M | 0.8% | NEW | — | |
| 36 | — | HELIX ACQUISITION CORP III | $1.4M | 0.8% | NEW | — |
| 37 | Compass Therapeutics, Inc. | $1.4M | 0.7% | -74% | — | |
| 38 | BITGO HOLDINGS, INC. | $1.2M | 0.7% | NEW | — | |
| 39 | COHERENT CORP. | $1.2M | 0.7% | NEW | 64 | |
| 40 | Janus Living, Inc. | $1.2M | 0.6% | NEW | — | |
| 41 | WhiteFiber, Inc. | $952,800 | 0.5% | -43% | 43.5 | |
| 42 | Vir Biotechnology, Inc. | $896,000 | 0.5% | NEW | 5.6 | |
| 43 | Gossamer Bio, Inc. | $845,282 | 0.5% | +16% | 27.1 | |
| 44 | Energy Vault Holdings, Inc. | $582,295 | 0.3% | NEW | 12 | |
| 45 | Satellos Bioscience Inc. | $67,560 | 0.0% | NEW | — |
New Positions (30)
Exited Positions (24)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Monashee Investment Management LLC including:
Track Monashee Investment Management LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Monashee Investment Management LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Monashee Investment Management LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Monashee Investment Management LLC (SEC CIK: 1627608), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Monashee Investment Management LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.